Both medications may affect blood sugar levels, potentially leading to low blood sugar (hypoglycemia)
Use of XTT-assay to assess the cytotoxicity of different surfactants and metal salts in human keratinocytes (HaCaT)
The combination of GLP-1, GIP, and glucagon receptor activation produces complex effects on blood glucose
A notable pharmacokinetic paradox: despite a short half-life under 30 minutes, effects persist for weeks to months, attributed to gene pathway activation [PMID: 40789979]
Arriving prepared with questions helps patients make informed decisions
These symptoms may indicate serious conditions such as pancreatitis, gallbladder disease, or dehydration leading to acute kidney injury, which have been associated with the GLP-1 receptor agonist class and require prompt clinical review